<span style="line-height: 20.8px;">Shenzhen Hepalink Pharmaceutical, the Shenzhen-listed main business of China billionaire couple Li Li and Li Tan, will invest $60 million in TPG Biotechnology Partners V, which mainly targets biomedical technology and life science companies, Hepalink said today.</span>